Found: 24
Select item for more details and to access through your institution.
Mesothelin Expression and Survival Outcomes in Triple Receptor Negative Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2013, v. 13, n. 5, p. 378, doi. 10.1016/j.clbc.2013.05.001
- By:
- Publication type:
- Article
Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer.
- Published in:
- EMBO Molecular Medicine, 2012, v. 4, n. 1, p. 52, doi. 10.1002/emmm.201100187
- By:
- Publication type:
- Article
LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 12, p. 5490, doi. 10.1172/JCI72573
- By:
- Publication type:
- Article
Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survival.
- Published in:
- 2010
- By:
- Publication type:
- Report
Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer.
- Published in:
- Breast Cancer Research, 2012, v. 14, n. 5, p. 3343, doi. 10.1186/bcr3343
- By:
- Publication type:
- Article
EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2014, v. 33, n. 1, p. 1, doi. 10.1186/s13046-014-0058-9
- By:
- Publication type:
- Article
Inflammatory Breast Cancer (IBC) and Patterns of Recurrence.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 7, p. 1436, doi. 10.1002/cncr.22927
- By:
- Publication type:
- Article
Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapy.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 5, p. 1000, doi. 10.1002/cncr.21726
- By:
- Publication type:
- Article
El debate ético y de regulación sobre el uso de CRISPR-Cas9 en la línea germinal humana.
- Published in:
- Universitas Médica, 2021, v. 62, n. 4, p. 1, doi. 10.11144/Javeriana.umed62-4.derc
- By:
- Publication type:
- Article
The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer.
- Published in:
- PLoS ONE, 2016, v. 11, n. 4, p. 1, doi. 10.1371/journal.pone.0152585
- By:
- Publication type:
- Article
Breast Cancer Subtype and Baseline Characteristics from Diabetic Breast Cancer Patients are Not Different from Nondiabetics.
- Published in:
- Breast Journal, 2014, v. 20, n. 4, p. 434, doi. 10.1111/tbj.12294
- By:
- Publication type:
- Article
Genotype in BRCA-associated Breast Cancers.
- Published in:
- Breast Journal, 2013, v. 19, n. 1, p. 87, doi. 10.1111/tbj.12056
- By:
- Publication type:
- Article
Adjuvant Chemotherapy with Doxorubicin and Dacarbazine has No Effect in Recurrence-Free Survival of Malignant Phyllodes Tumors of the Breast.
- Published in:
- Breast Journal, 2007, v. 13, n. 6, p. 551, doi. 10.1111/j.1524-4741.2007.00510.x
- By:
- Publication type:
- Article
Breast Cancer In Focus: The Importance of Accuracy in HER2 Testing.
- Published in:
- Clinical Advances in Hematology & Oncology, 2012, v. 10, n. 8, p. 1
- By:
- Publication type:
- Article
Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancer.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 20, p. 4936, doi. 10.1002/cncr.27502
- By:
- Publication type:
- Article
A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 9, p. 2378, doi. 10.1002/cncr.26571
- By:
- Publication type:
- Article
Bisphosphonates and pathologic complete response to taxane- and anthracycline-based neoadjuvant chemotherapy in patients with breast cancer.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 2, p. 326, doi. 10.1002/cncr.26144
- By:
- Publication type:
- Article
Triple-negative breast cancer in Hispanic patients.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 16, p. 3658, doi. 10.1002/cncr.25961
- By:
- Publication type:
- Article
Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based study.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 9, p. 1819, doi. 10.1002/cncr.25682
- By:
- Publication type:
- Article
Pathologic Complete Response in Breast Cancer Patients Receiving Anthracycline- and Taxane-Based Neoadjuvant Chemotherapy.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 17, p. 4168, doi. 10.1002/cncr.25296
- By:
- Publication type:
- Article
Implications of Functional Proteomics in Breast Cancer.
- Published in:
- Oncologist, 2014, v. 19, n. 4, p. 328, doi. 10.1634/theoncologist.2013-0437
- By:
- Publication type:
- Article